(1 - 28 von 37
)
BayPATs Lizenznehmer Recardio bereits in klinischer ...BayPAT
www.baypat.de
— Roman Schenk, der Gründer und Aufsichtsratsvorsitzende von Recardio, rechnet damit, dass die geplanten 140 in die Studie einzuschließenden — Roman Schenk, der Gründer und Aufsichtsratsvorsitzende von Recardio, rechnet damit, dass die geplanten 140 in die Studie einzuschließenden ...
Recardio and FDA Reach Agreement on Pivotal Phase GlobeNewswire
www.globenewswire.com
— Roman Schenk, RECARDIO President commented: "We appreciate the positive agency feedback and are looking forward to contributing with this — Roman Schenk, RECARDIO President commented: "We appreciate the positive agency feedback and are looking forward to contributing with this ...
Heart drug trials halted over Brexit fears - BBCwww.bbc.com › news › uk-scotland-scotland-politic...
www.bbc.com
· Recardio's founder and president, Dr Roman Schenk, told the BBC he did not want to comment on UK politics. However, he confirmed that ...
History of Changes for Study: NCT
clinicaltrials.gov
Study Officials: Roman Schenk, MD Study Chair Recardio, Inc. Locations: United States, California. Cedars-Sinai Medical Center, Heart Institute
sortiert nach Relevanz / Datum